A Prospective Study of 18FDG-PET With CT Coregistration for Radiation Treatment Planning of Lymphomas and Other Hematologic Malignancies

被引:11
|
作者
Terezakis, Stephanie A. [1 ,4 ]
Schoeder, Heiko [2 ]
Kowalski, Alexander [1 ]
McCann, Patrick [1 ]
Lim, Remy [2 ]
Turlakov, Alla [2 ]
Gonen, Mithat [3 ]
Barker, Chris [1 ]
Goenka, Anuj [1 ]
Lovie, Shona [1 ]
Yahalom, Joachim [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10065 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Nucl Med, New York, NY 10065 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Stat, New York, NY 10065 USA
[4] Johns Hopkins Sch Med, Dept Radiat Oncol & Mol Radiat Sci, Baltimore, MD USA
关键词
POSITRON-EMISSION-TOMOGRAPHY; NON-HODGKINS-LYMPHOMA; RADIOTHERAPY; GUIDELINES; INDOLENT; FIELDS; IMPACT; PET;
D O I
10.1016/j.ijrobp.2014.02.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: This prospective single-institution study examined the impact of positron emission tomography (PET) with the use of 2-[F-18] fluoro-2-deoxyglucose and computed tomography (CT) scan radiation treatment planning (TP) on target volume definition in lymphoma. Methods and Materials: 118 patients underwent PET/CT TP during June 2007 to May 2009. Gross tumor volume (GTV) was contoured on CT-only and PET/CT studies by radiation oncologists (ROs) and nuclear medicine physicians (NMPs) for 95 patients with positive PET scans. Treatment plans and dose-volume histograms were generated for CT-only and PET/CT for 95 evaluable sites. Paired t test statistics and Pearson correlation coefficients were used for analysis. Results: 70 (74%) patients had non-Hodgkin lymphoma, 10 (11%) had Hodgkin lymphoma, 12 (10%) had plasma-cell neoplasm, and 3 (3%) had other hematologic malignancies. Forty-three (45%) presented with relapsed/refractory disease. Forty-five (47%) received no prior chemotherapy. The addition of PET increased GTV as defined by ROs in 38 patients (median, 27%; range, 5%-70%) and decreased GTV in 41 (median, 39.5%; range, 5%-80%). The addition of PET increased GTV as defined by NMPs in 27 patients (median, 26.5%; range, 5%-95%) and decreased GTV in 52 (median, 70%; range, 5%-99%). The intraobserver correlation between CT-GTV and PET-GTV was higher for ROs than for NMPs (0.94, P <.01 vs 0.89, P <.01). On the basis of Bland-Altman plots, the PET-GTVs defined by ROs were larger than those defined by NMPs. On evaluation of clinical TPs, only 4 (74%) patients had inadequate target coverage (D95 < 95%) of the PET-GTV defined by NMPs. Conclusions: Significant differences between the RO and NMP volumes were identified when PET was coregistered to CT for radiation planning. Despite this, the PET-GTVdefined by ROs and NMPs received acceptable prescription dose in nearly all patients. However, given the potential for a marginal miss, consultation with an experienced PET reader is highly encouraged when PET/CT volumes are delineated, particularly for questionable lesions and to assure complete and accurate target volume coverage. (C) 2014 Elsevier Inc.
引用
收藏
页码:376 / 383
页数:8
相关论文
共 50 条
  • [1] A Prospective Study of 18FDG-PET with CT scan Co-registration for Radiation Treatment Planning of Lymphoma and Hematologic Malignancies
    Terezakis, S. A.
    Schoder, H.
    Kowalski, A.
    McCann, P.
    Schmidtlein, C.
    Gonen, M.
    Kirov, A.
    Lovie, S.
    Yahalom, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S550 - S550
  • [2] 18FDG-PET with CT scan co-registration for radiation treatment planning of lymphoma patients
    Terezakis, S. A.
    Hunt, M. A.
    Schmidtlein, C. R.
    Gonen, M.
    Kirov, A. S.
    Gonzales, A. M.
    Schoder, H.
    Yahalom, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S535 - S536
  • [3] [18F]FDG-POSITRON EMISSION TOMOGRAPHY COREGISTRATION WITH COMPUTED TOMOGRAPHY SCANS FOR RADIATION TREATMENT PLANNING OF LYMPHOMA AND HEMATOLOGIC MALIGNANCIES
    Terezakis, Stephanie A.
    Hunt, Margie A.
    Kowalski, Alexander
    McCann, Patrick
    Schmidtlein, C. Ross
    Reiner, Anne
    Goenen, Mithat
    Kirov, Assen S.
    Gonzales, Anne Marie
    Schoeder, Heiko
    Yahalom, Joachim
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (03): : 615 - 622
  • [4] Assessment of external radiation dose rate after 18FDG-PET/CT examination
    Hanan Aldousari
    Nouf Abuhadi
    Mariam Izz
    Thekra Alshammari
    Zainab Ali
    Razan Aldaas
    Abdoelrahman Hassan Ali Bakry
    Ahmed Abukonna
    Abdulredha Esmail
    Egyptian Journal of Radiology and Nuclear Medicine, 54
  • [5] Assessment of external radiation dose rate after 18FDG-PET/CT examination
    Aldousari, Hanan
    Abuhadi, Nouf
    Izz, Mariam
    Alshammari, Thekra
    Ali, Zainab
    Aldaas, Razan
    Bakry, Abdoelrahman Hassan Ali
    Abukonna, Ahmed
    Esmail, Abdulredha
    EGYPTIAN JOURNAL OF RADIOLOGY AND NUCLEAR MEDICINE, 2023, 54 (01):
  • [6] A prospective study of 18FDG-pet scanning in preoperative melanoma patients.
    Brady, MS
    Akhurst, T
    Spanknebal, K
    Gonen, M
    Hilton, S
    Coit, D
    Larson, S
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 715S - 715S
  • [7] PET-Computed Tomography for Radiation Treatment Planning of Lymphoma and Hematologic Malignancies
    Terezakis, Stephanie A.
    Yahalom, Joachim
    PET CLINICS, 2011, 6 (02) : 165 - +
  • [8] PROSPECTIVE CLINICAL INVESTIGATION ON THE USE OF 18FDG-PET/CT FOR CURATIVE CHEMO-RT
    Hideghety, K.
    Cserhati, A.
    Zag, L.
    Nagy, Z.
    Laszlo, P.
    Lengyel, Z.
    RADIOTHERAPY AND ONCOLOGY, 2009, 92 : S161 - S162
  • [9] 18F-FDG PET-CT in radiation treatment planning for rectal cancer
    Garcia Vicente, A. M.
    Lozano Martin, E.
    Talavera Rubio, M. P.
    Bellon Guardia, M. E.
    Gonzalez Garcia, B.
    Palomar Munoz, A. M.
    Poblete Garcia, V. M.
    Pilkington Woll, J. P.
    Cepedello Boiso, I.
    Cordero Garcia, J. M.
    Perez Romasanta, L. A.
    Soriano Castrejon, A. M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S351 - S352
  • [10] The role of 18FDG-PET/CT for detection of suspected recurrence of Schwannoma after treatment
    Ghedini, P.
    Grassi, I.
    Tabacchi, E.
    Diodato, S.
    Castellucci, P.
    Cambioli, S.
    Palmerini, E.
    Ferarri, S.
    Fanti, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S397 - S397